Importer of Controlled Substances Application: Cerilliant Corporation, 32906-32908 [2018-15139]

Download as PDF 32906 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices Controlled substance Drug code Schedule DEPARTMENT OF JUSTICE Drug Enforcement Administration Methylphenidate ..... Amobarbital ............ Pentobarbital .......... Secobarbital ............ Codeine .................. Oxycodone ............. Hydromorphone ...... Hydrocodone .......... Methadone .............. Methadone intermediate. Morphine ................. Oripavine ................ Thebaine ................. Opium tincture ........ Oxymorphone ......... 1724 2125 2270 2315 9050 9143 9150 9193 9250 9254 II II II II II II II II II II 9300 9330 9333 9630 9652 II II II II II [Docket No. DEA–392] Importer of Controlled Substances Application: Cerilliant Corporation ACTION: [FR Doc. 2018–15138 Filed 7–13–18; 8:45 am] BILLING CODE 4410–09–P Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 15, 2018. Such persons may also file a written request for a hearing on the application on or before August 15, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette DATES: The company plans to manufacture the listed controlled substances in bulk for sale to its customers. Dated: July 10, 2018. John J. Martin, Assistant Administrator. Notice of application. Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 12, 2018, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665 applied to be registered as an importer of the following basic classes of controlled substances: sradovich on DSK3GMQ082PROD with NOTICES Controlled substance Drug code 3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. 4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. Pentedrone (a-methylaminovalerophenone) ................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... N,N-Dimethylamphetamine .............................................................................................................................................. Fenethylline ..................................................................................................................................................................... Methaqualone .................................................................................................................................................................. JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ 5-Fluoro-UR-144 and XLR11 [1-(5-Fluoropentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................. AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ................................................................... AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ................. ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .................................................................... JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ Alpha-ethyltryptamine ...................................................................................................................................................... Ibogaine ........................................................................................................................................................................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 2565 6250 7008 7011 7012 7019 7023 7024 7031 7035 7048 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 7297 7298 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 32907 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices sradovich on DSK3GMQ082PROD with NOTICES Controlled substance Drug code Lysergic acid diethylamide .............................................................................................................................................. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .............................................................................................. Marihuana ........................................................................................................................................................................ Parahexyl ......................................................................................................................................................................... Mescaline ......................................................................................................................................................................... 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) ........................................................................................... 3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 2,5-Dimethoxyamphetamine ............................................................................................................................................ JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 3,4-Methylenedioxyamphetamine .................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. 5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ Alpha-methyltryptamine ................................................................................................................................................... Bufotenine ........................................................................................................................................................................ Diethyltryptamine ............................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... Psilocybin ......................................................................................................................................................................... Psilocyn ........................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .................................................................................................. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E) ..................................................................................................... 2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ................................................................................................................. 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................ 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .................................................................................................. 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) .................................................................................................... 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ............................................................................................. 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) .................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) .................................................... 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) .................................................... 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ......................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... Desomorphine ................................................................................................................................................................. Etorphine (except HCl) .................................................................................................................................................... Codeine methylbromide ................................................................................................................................................... Heroin .............................................................................................................................................................................. Morphine-N-oxide ............................................................................................................................................................ Normorphine .................................................................................................................................................................... Pholcodine ....................................................................................................................................................................... U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. Acetylmethadol ................................................................................................................................................................ Allylprodine ...................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... Alphameprodine ............................................................................................................................................................... Alphamethadol ................................................................................................................................................................. Betacetylmethadol ........................................................................................................................................................... Betameprodine ................................................................................................................................................................ Betamethadol ................................................................................................................................................................... Betaprodine ..................................................................................................................................................................... Dextromoramide .............................................................................................................................................................. Dipipanone ....................................................................................................................................................................... Hydroxypethidine ............................................................................................................................................................. Noracymethadol ............................................................................................................................................................... Norlevorphanol ................................................................................................................................................................ Normethadone ................................................................................................................................................................. Racemoramide ................................................................................................................................................................ VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1 7315 7348 7360 7374 7381 7385 7390 7391 7392 7395 7396 7398 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7455 7458 7470 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 9055 9056 9070 9200 9307 9313 9314 9547 9551 9601 9602 9603 9604 9605 9607 9608 9609 9611 9613 9622 9627 9633 9634 9635 9645 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 32908 Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices Controlled substance Drug code Trimeperidine ................................................................................................................................................................... 1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... Tilidine ............................................................................................................................................................................. Para-Fluorofentanyl ......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. Beta-hydroxyfentanyl ....................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ Alpha-methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Thiofentanyl ..................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Methylphenidate .............................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Nabilone ........................................................................................................................................................................... 1-Phenylcyclohexylamine ................................................................................................................................................ Phencyclidine ................................................................................................................................................................... Phenylacetone ................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ Alphaprodine .................................................................................................................................................................... Dihydrocodeine ................................................................................................................................................................ Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Levomethorphan .............................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Levo-alphacetylmethadol ................................................................................................................................................. Noroxymorphone ............................................................................................................................................................. Racemethorphan ............................................................................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tapentadol ....................................................................................................................................................................... The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards and distribution to their research and forensic customers. Dated: July 10, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–15139 Filed 7–13–18; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE sradovich on DSK3GMQ082PROD with NOTICES [OMB Number 1121–NEW] Agency Information Collection Activities; Proposed eCollection eComments Requested; Approval of a New Collection; Comments Requested: National Survey of Victim Service Providers (NCVSP) Bureau of Justice Statistics, Department of Justice. AGENCY: ACTION: 60-day notice. VerDate Sep<11>2014 17:31 Jul 13, 2018 Jkt 244001 The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until September 14, 2018. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Barbara Oudekerk, Statistician, Bureau of Justice Statistics, 810 Seventh Street NW, Washington, DC 20531 (email: Barbara.a.oudekerk@usdoj.gov; telephone: 202–616–3904). SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information SUMMARY: PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 9646 9661 9750 9812 9813 9814 9815 9830 9831 9832 9833 9835 1105 1724 2125 2270 2315 2550 7379 7460 7471 8501 8603 9010 9120 9180 9190 9210 9220 9230 9273 9648 9668 9732 9737 9739 9740 9743 9780 Schedule I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. E:\FR\FM\16JYN1.SGM 16JYN1

Agencies

[Federal Register Volume 83, Number 136 (Monday, July 16, 2018)]
[Notices]
[Pages 32906-32908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15139]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Cerilliant 
Corporation

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before August 15, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before August 15, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been delegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on June 
12, 2018, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round 
Rock, Texas 78665 applied to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).            1233  I
Cathinone..........................            1235  I
Methcathinone......................            1237  I
4-Fluoro-N-methylcathinone (4-FMC).            1238  I
Pentedrone ([alpha]-                           1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC)..            1249  I
Naphyrone..........................            1258  I
N-Ethylamphetamine.................            1475  I
N,N-Dimethylamphetamine............            1480  I
Fenethylline.......................            1503  I
Methaqualone.......................            2565  I
JWH-250 (1-Pentyl-3-(2-                        6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1-                7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
5-Fluoro-UR-144 and XLR11 [1-(5-               7011  I
 Fluoropentyl)1H-indol-3-
 yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-            7012  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-
 1H-indazole-3-carboxamide).
JWH-019 (1-Hexyl-3-(1-                         7019  I
 naphthoyl)indole).
AB-PINACA (N-(1-amino-3-methyl-1-              7023  I
 oxobutan-2-yl)-1-pentyl-1H-
 indazole-3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H-               7024  I
 indazol-3-yl](naphthalen-1-
 yl)methanone.
AB-CHMINACA (N-(1-amino-3-methyl-1-            7031  I
 oxobutan-2-yl)-1-
 (cyclohexylmethyl)-1H-indazole-3-
 carboxamide.
ADB-PINACA (N-(1-amino-3,3-dimethyl-           7035  I
 1-oxobutan-2-yl)-1-pentyl-1H-
 indazole-3-carboxamide).
APINACA and AKB48 N-(1-Adamantyl)-1-           7048  I
 pentyl-1H-indazole-3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4-                     7081  I
 methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-                7104  I
 Pentyl-3-[(4-methoxy)-benzoyl]
 indole.
JWH-018 (also known as AM678) (1-              7118  I
 Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-               7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-                   7144  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-                         7173  I
 naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-           7200  I
 3-(1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-               7201  I
 naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2-                        7203  I
 chlorophenylacetyl) indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-              7222  I
 indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-                  7225  I
 fluoropentyl)-1H-indole-3-
 carboxylate).
Alpha-ethyltryptamine..............            7249  I
Ibogaine...........................            7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-           7297  I
 [(1R,3S)-3-hydroxycyclohexyl-
 phenol).
CP-47,497 C8 Homologue (5-(1,1-                7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).

[[Page 32907]]

 
Lysergic acid diethylamide.........            7315  I
2,5-Dimethoxy-4-(n)-                           7348  I
 propylthiophenethylamine (2C-T-7).
Marihuana..........................            7360  I
Parahexyl..........................            7374  I
Mescaline..........................            7381  I
2-(4-Ethylthio-2,5-dimethoxyphenyl)            7385  I
 ethanamine (2C-T-2).
3,4,5-Trimethoxyamphetamine........            7390  I
4-Bromo-2,5-dimethoxyamphetamine...            7391  I
4-Bromo-2,5-dimethoxyphenethylamine            7392  I
4-Methyl-2,5-dimethoxyamphetamine..            7395  I
2,5-Dimethoxyamphetamine...........            7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-               7398  I
 naphthoyl) indole).
3,4-Methylenedioxyamphetamine......            7400  I
5-Methoxy-3,4-                                 7401  I
 methylenedioxyamphetamine.
N-Hydroxy-3,4-                                 7402  I
 methylenedioxyamphetamine.
3,4-Methylenedioxy-N-                          7404  I
 ethylamphetamine.
3,4-Methylenedioxymethamphetamine..            7405  I
4-Methoxyamphetamine...............            7411  I
5-Methoxy-N-N-dimethyltryptamine...            7431  I
Alpha-methyltryptamine.............            7432  I
Bufotenine.........................            7433  I
Diethyltryptamine..................            7434  I
Dimethyltryptamine.................            7435  I
Psilocybin.........................            7437  I
Psilocyn...........................            7438  I
5-Methoxy-N,N-diisopropyltryptamine            7439  I
N-Ethyl-1-phenylcyclohexylamine....            7455  I
1-(1-Phenylcyclohexyl)pyrrolidine..            7458  I
1-[1-(2-                                       7470  I
 Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine.................            7493  I
4-Methyl-                                      7498  I
 alphapyrrolidinopropiophenone (4-
 MePPP).
2-(2,5-Dimethoxy-4-methylphenyl)               7508  I
 ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl)                7509  I
 ethanamine (2C-E).
2-(2,5-Dimethoxyphenyl) ethanamine             7517  I
 (2C-H).
2-(4-iodo-2,5-dimethoxyphenyl)                 7518  I
 ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl)               7519  I
 ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl)               7521  I
 ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)-                        7524  I
 propylphenyl) ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-                       7532  I
 dimethoxyphenyl) ethanamine (2C-T-
 4).
MDPV (3,4-                                     7535  I
 Methylenedioxypyrovalerone).
2-(4-bromo-2,5-dimethoxyphenyl)-N-             7536  I
 (2-methoxybenzyl) ethanamine (25B-
 NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-            7537  I
 (2-methoxybenzyl) ethanamine (25C-
 NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-           7538  I
 methoxybenzyl) ethanamine (25I-
 NBOMe).
Methylone (3,4-Methylenedioxy-N-               7540  I
 methylcathinone).
Butylone...........................            7541  I
Pentylone..........................            7542  I
alpha-pyrrolidinopentiophenone                 7545  I
 ([alpha]-PVP).
alpha-pyrrolidinobutiophenone                  7546  I
 ([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2-               7694  I
 iodobenzoyl) indole).
Desomorphine.......................            9055  I
Etorphine (except HCl).............            9056  I
Codeine methylbromide..............            9070  I
Heroin.............................            9200  I
Morphine-N-oxide...................            9307  I
Normorphine........................            9313  I
Pholcodine.........................            9314  I
U-47700 (3,4-dichloro-N-[2-                    9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                   9551  I
 dimethylamino)cyclohexylmethyl]ben
 zamide)).
Acetylmethadol.....................            9601  I
Allylprodine.......................            9602  I
Alphacetylmethadol except levo-                9603  I
 alphacetylmethadol.
Alphameprodine.....................            9604  I
Alphamethadol......................            9605  I
Betacetylmethadol..................            9607  I
Betameprodine......................            9608  I
Betamethadol.......................            9609  I
Betaprodine........................            9611  I
Dextromoramide.....................            9613  I
Dipipanone.........................            9622  I
Hydroxypethidine...................            9627  I
Noracymethadol.....................            9633  I
Norlevorphanol.....................            9634  I
Normethadone.......................            9635  I
Racemoramide.......................            9645  I

[[Page 32908]]

 
Trimeperidine......................            9646  I
1-Methyl-4-phenyl-4-                           9661  I
 propionoxypiperidine.
Tilidine...........................            9750  I
Para-Fluorofentanyl................            9812  I
3-Methylfentanyl...................            9813  I
Alpha-methylfentanyl...............            9814  I
Acetyl-alpha-methylfentanyl........            9815  I
Beta-hydroxyfentanyl...............            9830  I
Beta-hydroxy-3-methylfentanyl......            9831  I
Alpha-methylthiofentanyl...........            9832  I
3-Methylthiofentanyl...............            9833  I
Thiofentanyl.......................            9835  I
Methamphetamine....................            1105  II
Methylphenidate....................            1724  II
Amobarbital........................            2125  II
Pentobarbital......................            2270  II
Secobarbital.......................            2315  II
Glutethimide.......................            2550  II
Nabilone...........................            7379  II
1-Phenylcyclohexylamine............            7460  II
Phencyclidine......................            7471  II
Phenylacetone......................            8501  II
1-Piperidinocyclohexanecarbonitrile            8603  II
Alphaprodine.......................            9010  II
Dihydrocodeine.....................            9120  II
Ecgonine...........................            9180  II
Ethylmorphine......................            9190  II
Levomethorphan.....................            9210  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Dextropropoxyphene, bulk (non-                 9273  II
 dosage forms).
Levo-alphacetylmethadol............            9648  II
Noroxymorphone.....................            9668  II
Racemethorphan.....................            9732  II
Alfentanil.........................            9737  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Tapentadol.........................            9780  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the manufacture of analytical reference 
standards and distribution to their research and forensic customers.

    Dated: July 10, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-15139 Filed 7-13-18; 8:45 am]
 BILLING CODE 4410-09-P